{"nct_id":"NCT02212730","title":"A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)","status":"TERMINATED","status_verified_date":"2020-06","start_date":"2014-12-03","start_date_type":"ACTUAL","primary_completion_date":"2019-07-05","primary_completion_date_type":"ACTUAL","completion_date":"2019-07-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}